Scemblix

asciminib

Approval

ApplicationNDA 215358
Approval dateOct 29, 2021
Approval year2021
SponsorNovartis

FDA-approved use

To treat Philadelphia chromosome-positive chronic myeloid leukemia with disease that meets certain criteria

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Scemblix: